[FenicsBio] AsPC-1 SMAD/TGFbeta Reporter (Luc) stable cell line
| Package Size | 2 x 10^6 cells |
| Parental cell line | AsPC-1 cells |
| Transgenic gene | Firefly luciferase |
| Mammalian selection | Puromycin |
| Biosafety level | 2 |
| Storage | Liquid nitrogen |
| Availability | 3-4 weeks |
| Shipping condition | dry ice |
Catalog number
CL-1471
Description
AsPC-1 SMAD/TGFbeta Reporter (Luc) cells are derived from the human pancreas adenocarcinoma AsPC-1 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. AsPC-1 cell line has been widely used in cancer research and drug development. AsPC-1 SMAD/TGFbeta Reporter (Luc) cells express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for in vitro assays and in vivo imaging.
'FenicsBio' 카테고리의 다른 글
| [FenicsBio] CMV-Cas9 lentivirus (Hyg) (0) | 2023.03.13 |
|---|---|
| [FenicsBio] LentiShield lentivirus storage buffer (0) | 2023.01.27 |
| [FenicsBio] Lentiviral Firefly luciferase reporter cloning vector (Puro) (0) | 2022.10.26 |
| [FenicsBio]Lentiviral sgRNA Cloning Vector (U6, Neo) (0) | 2022.09.30 |
| [FenicsBio] LentiShield lentivirus storage buffer (0) | 2022.09.26 |
